Non-vascular Stents Market Size To Reach $2.27 Billion By 2030

Non-vascular Stents Market Growth & Trends

The global non-vascular stents market size is expected to reach USD 2.27 billion by 2030, registering a CAGR of 4.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness lucrative growth during the forecast period due to technological advancements in the non-vascular stents and rise in the adoption of minimally invasive surgeries across the world.

Technological advancements such as the development of radioactive & biodegradable stents, advanced stent designs & change in material composition, and newer stent placement techniques, such as Endoscopic Ultrasound-guided (EUS) stenting, are expected to help in the growth of the non-vascular stents market over the forecast period. Various materials such as metallic stents, made from alloys include nitinol, silicone & nitinol, stainless steel, and elgiloy (cobalt-chromium-nickel Alloy) and nonmetallic stents, made from synthetic polymers such as resins, polyurethane, and silicone, are used as per the requirement as they offer different features.

Due to the high adoption of minimally invasive techniques, such as nonvascular stenting, by healthcare professionals, the market is expected to grow. This can be attributed to the various advantages such as smaller incisions, rapid wound healing, and reduced pain & surgical scars. Smaller incisions and surgical wounds result in lesser complications, which significantly reduces the overall surgery cost. Moreover, minimally invasive surgeries result in reduced hospital stay, which ultimately lowers the risk of hospital-acquired infections in patients. This helps reduce the overall healthcare expenditure of patients.

 Request a free sample copy or view report summary: Non-vascular Stents Market Report

Non-vascular Stents Market Report Highlights

• Biliary stents dominated the market in 2023 due to increasing occurrence of liver and bile duct diseases such as cholangiocarcinoma and gallstones resulting in a rising need for less invasive methods to deal with blockages.

• The gastrointestinal stents segment is expected to register the highest growth over the forecast period owing to surge in the number of cases of gastrointestinal cancer, such as cancer of the esophagus, stomach, gallbladder, small intestine, pancreas, liver, bowel, and anus

• North America is expected to dominate the market during the forecast period owing to the local presence of major market players and robust healthcare infrastructure coupled with a high prevalence of gastrointestinal cancer in the U.S. & Canada.

Non-vascular Stents Market Segmentation

Grand View Research has segmented the global non-vascular stents market based on type, end use, and region:

Non-vascular Stents Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Gastrointestinal Stents

• Biliary

• Duodenal

• Colonic

• Pancreatic

• Esophageal Stents

• Pulmonary (Airway) Stents

• Silicone Airway

• Metallic Airway

• Urological Stents

• Others

Non-vascular Stents End Use Outlook (Revenue, USD Billion, 2018 – 2030)

• Hospitals

• Ambulatory Care Centers (ACS)

• Specialty Clinics 

Non-vascular Stents Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • KSA

  • UAE

  • South Arabia

  • South Africa

List Of Key Players Non-vascular Stents Market

• Medtronic

• BD

• Boston Scientific Corporation

• ELLA - CS, s.r.o.

• CONMED Corporation

• HOBBS MEDICAL, INC

• Cook

• TAEWOONG

• Glaukos Corporation